<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Damora Therapeutics, Inc. (DMRA) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/dmra/filings</link>
    <description>Latest company filings for Damora Therapeutics, Inc. (DMRA) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 23:16:13 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/dmra/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000091957426003477/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000919574-26-003477</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000090266426002524/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-002524</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000090266426002463/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-002463</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526219327/dmra-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-219327</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526214909/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-214909</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526203913/dmra-20260428.htm</link>
      <guid isPermaLink="false">0001193125-26-203913</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-04.]]></description>
      <pubDate>Mon, 04 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526201367/dmra_123125_ars.pdf</link>
      <guid isPermaLink="false">0001193125-26-201367</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526191429/dmra-20260429.htm</link>
      <guid isPermaLink="false">0001193125-26-191429</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526191426/dmra-20260429.htm</link>
      <guid isPermaLink="false">0001193125-26-191426</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526174461/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-174461</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526174454/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-174454</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526163909/dmra-20260417.htm</link>
      <guid isPermaLink="false">0001193125-26-163909</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526138275/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-138275</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526138247/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-138247</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124487/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124487</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124483/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124483</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124476/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124476</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124471/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124471</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124466/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124466</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124455/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124455</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124447/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124447</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526124440/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-124440</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526118699/dmra-20260320.htm</link>
      <guid isPermaLink="false">0001193125-26-118699</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526117594/dmra-20260320.htm</link>
      <guid isPermaLink="false">0001193125-26-117594</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526115922/dmra-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-115922</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526099404/dmra-20260306.htm</link>
      <guid isPermaLink="false">0001193125-26-099404</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526096746/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-096746</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-06.]]></description>
      <pubDate>Fri, 06 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000173804826000036/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001738048-26-000036</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000090266426001154/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-001154</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526047537/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-047537</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-02-12.]]></description>
      <pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526047535/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-047535</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-02-12.]]></description>
      <pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526047007/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-047007</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-02-11.]]></description>
      <pubDate>Wed, 11 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526046817/d38009d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-046817</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-11.]]></description>
      <pubDate>Wed, 11 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526046779/d41040d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-046779</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-02-11.]]></description>
      <pubDate>Wed, 11 Feb 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526044766/d41040d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-044766</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[DMRA: S-3ASR]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526044613/d291219ds3asr.htm</link>
      <guid isPermaLink="false">0001193125-26-044613</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a S-3ASR (S-3ASR) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-3ASR</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526043741/glto-20260206.htm</link>
      <guid isPermaLink="false">0001193125-26-043741</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526023094/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-023094</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-01-26.]]></description>
      <pubDate>Mon, 26 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526023089/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-023089</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-01-26.]]></description>
      <pubDate>Mon, 26 Jan 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526010366/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-010366</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[DMRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526010344/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-010344</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526009812/glto-20260112.htm</link>
      <guid isPermaLink="false">0001193125-26-009812</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526006723/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006723</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526006720/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006720</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a New insider ownership (3) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526004573/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004573</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526004568/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004568</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526004565/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-004565</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Insider trade (4) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526003490/glto-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-003490</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[DMRA: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312526001076/glto-20260102.htm</link>
      <guid isPermaLink="false">0001193125-26-001076</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-01-02.]]></description>
      <pubDate>Fri, 02 Jan 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[DMRA: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/0/000119312525338281/d98130d424b3.htm</link>
      <guid isPermaLink="false">0001193125-25-338281</guid>
      <description><![CDATA[Damora Therapeutics, Inc. filed a 424B3 (424B3) on 2025-12-31.]]></description>
      <pubDate>Wed, 31 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
  </channel>
</rss>